Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul><li>Organto reported Q1 financials that were slightly ahead of our expectations and its pre-announced Q1 metrics.</li><li>Organto Foods (OGO:TSXV) reported Q1/23 financial results yesterday evening that came in slightly ahead of our expectations.</li><li>OGO reported $7.5M in revenue in Q1, compared to our estimate of $7.4M and $7.0M in Q1 last year.</li></ul>

Organto reported Q1 financials that were slightly ahead of our expectations and its pre-announced Q1 metrics.Organto Foods (OGO:TSXV) reported Q1/23 financial results yesterday evening that came in slightly ahead of our expectations.OGO reported $7.5M in revenue in Q1, compared to our estimate of $7.4M and $7.0M in Q1 last year.

OGO: Strong Q1 Financial Results, Gross Margin Tracking Higher